Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Neurobiol Learn Mem ; 137: 163-170, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27916533

ABSTRACT

Noradrenaline (NA), released by the locus coeruleus (LC), plays a key role in mediating the effects of stress on memory functions. The LC provides diffuse projections to many forebrain nuclei including the hippocampus, the prefrontal cortex (PFC), and the basolateral amygdala (BLA). These three structures are intricately interlinked. The hippocampal-prefrontal (H-PFC) pathway is involved in various cognitive functions. The first aim of this study was to examine the role of BLA in H-PFC plasticity by infusion of drugs to activate and inactivate the BLA and studying the effects on H-PFC long-term potentiation (LTP) in the rat in vivo. Activation of the BLA with glutamate impaired, while inactivation with muscimol augmented, H-PFC LTP. This study also aimed to demonstrate how directly applying noradrenaline and other noradrenergic agents in the BLA can affect H-PFC LTP. Noradrenaline at 1µg/0.2µl enhanced H-PFC LTP. Stimulating alpha-2-adrenoceptors in the BLA with clonidine enhanced LTP while blocking alpha-2 adrenoceptors with idazoxan impaired it. Propranolol, a non-selective beta antagonist, enhanced H-PFC LTP while isoprenaline, a non-selective beta agonist, decreased H-PFC LTP. These results suggest that the BLA regulates H-PFC plasticity negatively and also provide a mechanism by which noradrenaline in the BLA can affect H-PFC plasticity via alpha-2 and beta adrenoceptors.


Subject(s)
Adrenergic alpha-2 Receptor Agonists/pharmacology , Adrenergic alpha-2 Receptor Antagonists/pharmacology , Adrenergic beta-Agonists/pharmacology , Adrenergic beta-Antagonists/pharmacology , Basolateral Nuclear Complex/drug effects , Hippocampus/drug effects , Long-Term Potentiation/drug effects , Prefrontal Cortex/drug effects , Animals , Clonidine/pharmacology , Idazoxan/pharmacology , Isoproterenol/pharmacology , Male , Norepinephrine/pharmacology , Propranolol/pharmacology , Rats , Rats, Sprague-Dawley
2.
IEEE Trans Pattern Anal Mach Intell ; 32(10): 1795-808, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20724757

ABSTRACT

Topic detection (TD) is a fundamental research issue in the Topic Detection and Tracking (TDT) community with practical implications; TD helps analysts to separate the wheat from the chaff among the thousands of incoming news streams. In this paper, we propose a simple and effective topic detection model called the temporal Discriminative Probabilistic Model (DPM), which is shown to be theoretically equivalent to the classic vector space model with feature selection and temporally discriminative weights. We compare DPM to its various probabilistic cousins, ranging from mixture models like von-Mises Fisher (vMF) to mixed membership models like Latent Dirichlet Allocation (LDA). Benchmark results on the TDT3 data set show that sophisticated models, such as vMF and LDA, do not necessarily lead to better results; in the case of LDA, notably worst performance was obtained under variational inference, which is likely due to the significantly large number of LDA model parameters involved for document-level topic detection. On the contrary, using a relatively simple time-aware probabilistic model such as DPM suffices for both offline and online topic detection tasks, making DPM a theoretically elegant and effective model for practical topic detection.

3.
Int J Neuropsychopharmacol ; 13(9): 1219-31, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20128952

ABSTRACT

Stimulation of the subiculum/CA1 of the hippocampal formation evokes monosynaptic field potentials in the prefrontal cortex (PFC). High-frequency stimulation of the hippocampus (HPC) can induce long-term potentiation (LTP) in this hippocampo-prefrontal cortical (hippo-PFC) pathway. Previous studies have shown that dopamine and serotonin modulate hippo-PFC LTP. Here, we investigated whether the locus coeruleus (LC) and noradrenaline (NA) can modulate LTP in the rat hippo-PFC pathway. Stimulation of the LC in combination with stimulation of the HPC increased hippo-PFC LTP. Infusion of lidocaine into the LC reduced hippo-PFC LTP. Administration of the noradrenaline reuptake inhibitor, nisoxetine or the alpha2 adrenoceptor antagonist, idazoxan prior to high-frequency stimulation of the HPC enhanced hippo-LTP. In contrast, administration of clonidine, an alpha2 adrenoceptor agonist, impaired hippo-PFC LTP. Partial noradrenergic (NAergic) lesioning with DSP-4 also impaired hippo-PFC LTP. In conclusion, the LC and NAergic mechanisms modulate hippo-PFC LTP.


Subject(s)
Hippocampus/drug effects , Locus Coeruleus/drug effects , Long-Term Potentiation , Norepinephrine/metabolism , Prefrontal Cortex/drug effects , Prefrontal Cortex/metabolism , Adrenergic Agents/metabolism , Adrenergic Agents/pharmacology , Adrenergic alpha-2 Receptor Antagonists/metabolism , Adrenergic alpha-2 Receptor Antagonists/pharmacology , Adrenergic alpha-Agonists/metabolism , Adrenergic alpha-Agonists/pharmacology , Animals , Benzylamines/metabolism , Benzylamines/pharmacology , Clonidine/metabolism , Clonidine/pharmacology , Dopamine/metabolism , Dopamine/physiology , Hippocampus/metabolism , Hippocampus/physiology , Idazoxan/metabolism , Idazoxan/pharmacology , Locus Coeruleus/physiology , Long-Term Potentiation/drug effects , Male , Prefrontal Cortex/physiology , Rats , Rats, Sprague-Dawley , Serotonin/metabolism , Serotonin/physiology
4.
Psychopharmacology (Berl) ; 191(2): 297-310, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17225165

ABSTRACT

RATIONALE: Atypical antipsychotics improve cognitive function, including working memory, in schizophrenia. Some atypical antipsychotics have been reported to activate the locus coeruleus and induce beta-adrenoceptor antagonist sensitive c-Fos-like immunoreactivity in the prefrontal cortex. MATERIALS AND METHODS: The present study investigated the effects of chronic treatment of rats with risperidone (1 mg kg(-1) day(-1) s.c.), clozapine (10 mg kg(-1) day(-1) s.c.), or acidified saline vehicle control for 2, 4, or 8 weeks on spatial working memory performance in a delayed matching-to-place water maze task with a 60-s inter-trial retention interval with and without acute challenge with propranolol (10 mg/kg i.p.). RESULTS: Treatment with risperidone for 8 weeks, but not 2 or 4 weeks, significantly improved working memory performance. In contrast, treatment with clozapine for up to 8 weeks did not improve working memory. Acute challenge with propranolol blocked the improvement in working memory produced by chronic treatment with risperidone, but had no significant effect on performance in saline- or clozapine-treated animals. CONCLUSIONS: The delayed matching-to-place water maze task may prove valuable in the investigation of the behavioural pharmacology of the cognitive effects of antipsychotic drugs. These data suggest that beta adrenoceptors may contribute to the cognitive effects of chronic treatment with atypical antipsychotics.


Subject(s)
Adrenergic beta-Antagonists/pharmacology , Antipsychotic Agents/pharmacology , Memory/drug effects , Propranolol/pharmacology , Risperidone/pharmacology , Analysis of Variance , Animals , Behavior, Animal/drug effects , Clozapine/pharmacology , Disease Models, Animal , Drug Administration Schedule , Drug Interactions , Male , Maze Learning/drug effects , Rats , Rats, Sprague-Dawley , Schizophrenia , Space Perception/drug effects
5.
Neurosci Res ; 57(1): 17-28, 2007 Jan.
Article in English | MEDLINE | ID: mdl-17028028

ABSTRACT

Acute administration of clozapine has been reported to activate the locus coeruleus (LC) and beta-adrenoceptor-dependent Fos immunoreactivity in the medial prefrontal cortex (mPFC) in rodents. Haloperidol is reported to exhibit a similar acute effect on LC firing and beta-adrenoceptor dependent Fos immunoreactivity in the mPFC but only at high doses. We compared the effects of chronic 4-week treatment with risperidone (1mg/kg/day s.c.), clozapine (10mg/kg/day s.c.) or a high dose of haloperidol (4mg/kg/day s.c.) on immediate-early gene protein (c-Fos, Egr-1 and Egr-2) and tyrosine hydroxylase (TH) expression. In the mPFC, haloperidol decreased, whereas clozapine increased, c-Fos immunoreactivity. Only haloperidol increased Egr-1 immunoreactivity. There was no significant effect on Egr-2 immunoreactivity. In the LC, both Egr-1 and Egr-2 expression was down regulated by all three antipsychotics. Clozapine and risperidone increased TH immunoreactivity in both mPFC and LC. Haloperidol caused a smaller increase in TH expression in the LC, but did not alter expression in the mPFC. In conclusion, despite qualitatively similar effects in the LC, chronic treatment with haloperidol had different effects to clozapine and risperidone in the mPFC. This may relate to the reported advantage of clozapine and risperidone over haloperidol against prefrontal cortical-dependent cognitive and negative symptoms.


Subject(s)
Antipsychotic Agents/pharmacology , Gene Expression/drug effects , Immediate-Early Proteins/metabolism , Locus Coeruleus/drug effects , Prefrontal Cortex/drug effects , Tyrosine 3-Monooxygenase/metabolism , Animals , Cell Count/methods , Clozapine/pharmacology , Genes, Immediate-Early/physiology , Haloperidol/pharmacology , Immunohistochemistry/methods , Locus Coeruleus/cytology , Male , Neurons/drug effects , Neurons/metabolism , Prefrontal Cortex/cytology , Rats , Rats, Sprague-Dawley , Risperidone/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...